Article · 2020
Editorial Board Member
Suowen Xu
National Institutes of Health, USA
About
As published by the journal they serve.
Suowen Xu is currently a visiting fellow of National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, USA. The goal of Dr. Xus research is to identify the molecular mechanisms of cardiac hypertrophy and atherosclerosis, and to explore effective therapeutics from Traditional Chinese Medicine, such as Danshen. Dr. Xu now is working on biochemistry of mono-ADP-ribosylation and poly-ADP-ribosylation, a reversible post-translational modification of proteins. Dr. Xu has received numerous honors, including the United States “Committee of 100 (C-100)” Leadership Scholarship, “New Investigator Award” of Ministry of Education of China, “Bayer China Development Fund” Scholarship, and International Health Exchange and Cooperation Center (China) and Daiichi-Sankyo (Japan) Fellowship. He serves as a trainee member of American Heart Association (AHA)-ATVB council. He received his B.Sc. in Traditional Chinese Medicine from Anhui University of Traditional Chinese Medicine, and Ph.D. in cardiovascular pharmacology from Sun Yat-sen University, China.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Vascular Medicine & SurgeryEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2020
Editor Note: Vascular Medicine and Surgery
Article · 2013
Rock the Rock of Atherosclerosis
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
